A Dose Ranging Trial of 4 Doses of Indacaterol Delivered Via TWISTHALER® Device in Adult and Adolescent Patients With Persistent Asthma

PHASE2CompletedINTERVENTIONAL
Enrollment

392

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

April 30, 2008

Study Completion Date

April 30, 2008

Conditions
Asthma
Interventions
DRUG

indacaterol

Indacaterol delivered by multiple dose dry powder inhaler (TWISTHALER® device).

DRUG

formoterol

Formoterol delivered by oral inhalation via AEROLIZER® inhalation device.

DRUG

placebo to indacaterol

Placebo TWISTHALER® device

DRUG

placebo to formoterol

Placebo AEROLIZER® device

DRUG

short acting β2-agonist

100 μg/ 90 μg salbutamol/albuterol Metered Dose Inhaler (MDI) or equivalent dose of Dry Powder Inhaler (DPI).

Trial Locations (60)

Unknown

Novartis Investigator Site, Aalst

Novartis Investigator Site, Halen

Novartis Investigator Site, Oostham

Novartis Investigator site, Veurne

Novartis Investigator Site, Boskovice

Novartis Investigator Site, Brno

Novartis Investigator site, Břeclav

Novartis Investigator Site, Liberec

Novartis Investigator Site, Most

Novartis Investigator Site, Tábor

Novartis Investigator Site, Aalen

Novartis Investigator Site, Berlin

Novartis Investigator Site, Braunschweig

Novartis Investigator Site, Deggendorf

Novartis Investigator Site, Fürstenwalde

Novartis Investigator Site, Leipzig

novartis Investigator site, München

Novartis investigator site, Balassagyarmat

Novartis Investigator Site, Érd

Novartis Investigator site, Füzesabony

Novartis Investigator Site, Gyonggyos

Novartis Investigator Site, Mosdoz

Novartis Investigator Site, Pest

Novartis Investigator Site, Siófok

Novartis Investigator Site, Százhalombatta

Novartis Investigator Site, Afula

Novartis Investigator Site, Ashkelon

Novartis Investigator Site, Beersheba

Novartis investigator site, Haifa

Novartis investigator site, Jerusalem

Novartis Investigator Site, Petah Tikva

Novartis Investigator Site, Rehovot

Novartis Investigator Site, Tel Aviv

Novartis Investigator Site, Tel-Hashorner

Novartis Investigator Site, Zrifin

Novartis Investigator Site, Bialystok

Novartis investigator site, Bydgoszcz

Novartis Investigator Site, Lodz

Novartis Investigator site, Lubin

Novartis Investigator Site, Tarnów

Novartis Investigator Site, Moscow

Novartis Investigator Site, Saint Petersburg

Novartis Investigator Site, Smolensk

Novartis investigator site, Tomsk

Novartis Investigator Site, Bloernfontain

Novartis Investigator Site, Cape Town

Novartis Investigator Site, Johannesburg

Novartis Investigator Site, Krugersdorp

Novartis Investigator Site, Les Marais

Novartis Investigator Site, Pretoria

Novartis Investigator Site, Roodepoort

Novartis Investigator Site, Themba

Novartis Investigator Site, Madrid

Novartis Investigator Site, Pozuelo de Alacron

Novartis Investigator Site, Valencia

Novartis Investigator Site, Downpatrick

Novartis Investigator Site, Glasgow

Novartis Investigator Site, London

Novartis Investigator Site, Southampton

Novartis Investigator Site, Watford

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Schering-Plough

INDUSTRY

lead

Novartis Pharmaceuticals

INDUSTRY